Human immunodeficiency virus (HIV) infection continues to be a major global health problem, with an estimated 33 million people infected as of 2007. In the United States, more than 1.1 million people are infected with HIV (Centers for Disease Control and Prevention 2009). Although effective treatment of HIV infection has substantially decreased HIV-related mortality, HIV still is the sixth leading cause of death for adults aged 25--44 in the United States (<http://www.cdc.gov/hiv/topics/surveillance/resources/slides/mortality/slides/mortality.pdf>).

Recent data indicate that new HIV cases have not decreased in recent years and may actually be increasing in men who have sex with men, a trend observed both in North America and in Asia (<http://www.unaids.org/en/KnowledgeCentre/HIVData/GlobalReport>) ([@b58-arh-33-3-203]).

Alcohol is the most commonly abused substance in the United States, and people with HIV are more likely to use alcohol than the general population. Whereas the rate of alcohol abuse is approximately 4.6 percent in the general U.S. population ([@b53-arh-33-3-203]), 8 percent of HIV-infected individuals in U.S. cohorts can be classified as heavy drinkers ([@b47-arh-33-3-203]). The prevalence of hazardous drinking in HIV-infected U.S. veterans is 20 percent, with 67 percent considered to drink "too much" at some point by their health care providers ([@b31-arh-33-3-203]). The rate is even greater among homosexual/bisexual men (41 percent) ([@b81-arh-33-3-203]). Heavy drinking in HIV patients correlates with illicit drug use (cocaine and heroin), lower educational status, and male gender ([@b47-arh-33-3-203]).

Given the high prevalence of substance abuse in the HIV population, deciphering the effects of alcohol and other drugs on HIV transmission, disease progression, and treatment response is a high research priority. This article will review evidence showing that excessive alcohol consumption is detrimental to the HIV-infected patient in several aspects (see [figure 1](#f1-arh-33-3-203){ref-type="fig"}). Topics discussed include the effect of alcohol abuse on HIV transmission, viral replication, host immune system, and efficacy of treatment to keep HIV levels low (i.e., antiretroviral \[ARV\] therapy \[ART\]). The article also will present data showing the effect of alcohol intake on simian immunodeficiency virus (SIV) pathogenesis in rhesus macaques, the animal model of choice for HIV infection. Finally, the article will discuss potential research avenues in nonhuman primate (NHP) animal models that can be used to further our understanding of the role of the alcohol in the natural history of acquired immune deficiency syndrome (AIDS).

Alcohol's Role in HIV Transmission
==================================

As stated above, alcohol intake increases the rate of HIV transmission through multiple mechanisms, as reviewed below and shown in [figure 2](#f2-arh-33-3-203){ref-type="fig"}.

Behavioral Effects
------------------

Alcohol use causes disinhibition and diminished perception of risk, which increase the likelihood that a person would put him or herself (or his/her partner) at risk for HIV infection by engaging in unsafe sexual practices, such as having multiple sex partners, unprotected intercourse, sex with high-risk partners (e.g., injection drug users, prostitutes), and exchanging sex for money or drugs ([@b76-arh-33-3-203]; [@b178-arh-33-3-203]). However, this issue still is being debated ([@b139-arh-33-3-203]; [@b148-arh-33-3-203]; [@b169-arh-33-3-203]).

Sexual promiscuity triggered by alcohol abuse also increases the risk of acquiring other sexually transmitted diseases (STDs) ([@b178-arh-33-3-203]), and people with STDs are at risk for both transmitting and acquiring HIV ([@b175-arh-33-3-203]). STDs appear to increase susceptibility to HIV infection by two mechanisms. Ulcerative STDs such as syphilis, herpes, or chancroid cause breaks in the genital tract lining or skin, creating a portal of entry for HIV. Genital ulcers or nonulcerative STDs such as chlamydiosis, gonorrhea, and trichomoniasis induce inflammation in the genital tract, thus increasing the concentration of cells in genital secretions that can serve as targets for HIV (e.g., CD4^+^ T-cells, a type of white blood cell involved in cell-mediated immunity which also serve as host cells that aid HIV in replication). STDs also appear to increase the risk of an HIV-infected person transmitting the virus, as people with HIV who present with other STDs are shedding more HIV in their genital secretions than are those who are infected with HIV only ([@b73-arh-33-3-203]; [@b116-arh-33-3-203]). Moreover, the concentration of HIV in semen is significantly higher in patients coinfected with the bacteria responsible for gonorrhea ([@b133-arh-33-3-203]).

Physiological Effects
---------------------

Aside from behavioral impacts, alcohol abuse may increase host transmissibility through other mechanisms. By increasing viral replication in HIV-infected patients, alcohol may increase the virus concentration in the semen and in the vagina and thus facilitate HIV transmission. Thus, moderate to heavy alcohol consumption is positively correlated with vaginal shedding of HIV in patients on ART, even after adjusting for medication compliance ([@b168-arh-33-3-203]). By interacting with diverse components of the immune system, alcohol may increase immune activation and inflammation in the HIV-infected patient and thus increase the pool of HIV target cells systemically and at transmission sites. In addition, alcohol may be responsible for changes in vaginal flora, which may induce inflammation and thus increase the rates of HIV transmission ([@b30-arh-33-3-203]; [@b140-arh-33-3-203]).

Other factors that may contribute to the increased spreading of HIV----such as high levels of viral replication and resistance, increased levels of immune activation, and accelerated disease progression----have been reported to occur in medication noncompliant HIV-infected patients that abuse alcohol.

Altogether, these data clearly suggest that alcohol consumption has a negative effect on HIV transmission and that specific interventions should be developed for substance abuse treatment in the HIV population. These interventions should particularly target women and teenagers, the segment of the population in which most of the new cases arise and in which alcohol plays an important role in HIV transmission.

Alcohol's Effects on HIV Pathogenesis
=====================================

Although earlier studies did not find an association between alcohol consumption and markers of HIV disease progression ([@b69-arh-33-3-203]), recent research has found a significant association between heavy alcohol consumption and lower levels of CD4^+^ T-cells among HIV-infected alcoholic patients not receiving ART ([@b142-arh-33-3-203]). This effect was not observed among moderate drinkers, however, or among patients adherent to ART. Additionally, alcohol consumption was not associated with higher viral levels in plasma (a blood component).

In women, recent alcohol consumption was significantly associated with the presence of HIV in vaginal secretions ([@b168-arh-33-3-203]). Plasma viral levels were not associated with recent alcohol consumption, and associations between alcohol use and levels of HIV in the genitals were not observed among women taking ART.

Although these observational studies provide evidence that alcohol use affects viral replication or HIV disease within a host, they also highlight the complexities of study design and of assessing human behavior over a lengthy and variable disease course. To more clearly delineate the associations between alcohol use and HIV disease, investigators have turned to studies using controlled laboratory environments (in vitro) as opposed to studies in living organisms (in vivo).

Virus Entry and Replication
---------------------------

In a study of blood cells taken from HIV-positive study participants, researchers found that the virus replicates to higher levels in cells taken after alcohol consumption compared with cells obtained before alcohol was consumed ([@b6-arh-33-3-203]). The cells obtained after alcohol ingestion also displayed a reduced capacity for producing interleukin (IL)-2, a molecule that carries signals between cells (i.e., a cytokine) important in immunity. The increased in vitro HIV replication in blood cells from alcohol users also was associated with the inhibition of CD8^+^ T-cells, which attack infected cells ([@b5-arh-33-3-203]).

HIV strains can bind with two specific molecules on the cell surface (i.e., receptors): the chemokine coreceptors CCR5 and CXCR4. Alcohol exposure increases the number of cells with the CXCR4 coreceptor, resulting in enhanced early replication of viral subtypes that use CXCR4 as a coreceptor ([@b88-arh-33-3-203]). The number of cells expressing the coreceptor CCR5 decreases following alcohol exposure, and, consequently, alcohol treatment of blood cells does not affect the early replication of CCR5-utilizing HIV subtypes, compared with controls. Similarly, in vitro exposure of human skin cells from the mouth to alcohol increases surface expression of CXCR4 and enhances in vitro replication of HIV in these cells ([@b27-arh-33-3-203]). These in vitro studies identified possible mechanisms by which alcohol may affect the dynamics of HIV infection and replication in the body.

Alcohol's Effects on the Immune System
--------------------------------------

Alcohol consumption affects various components of the immune system, with both chronic and acute alcohol consumption disrupting immune functions ([@b34-arh-33-3-203]; [@b52-arh-33-3-203]; [@b79-arh-33-3-203]; [@b99-arh-33-3-203]; [@b112-arh-33-3-203]; [@b120-arh-33-3-203]; [@b163-arh-33-3-203]). However, little is known regarding the direct interactions between alcohol-induced immunological changes and those induced by HIV infection.

Acute and chronic alcohol consumption have differential effects on the nonspecific (i.e., innate) and acquired (i.e., adaptive) arms of the immune system ([@b52-arh-33-3-203]).

### Effects of Acute Alcohol Exposure

Acute alcohol exposure suppresses the production of proinflammatory cytokines, including tumor necrosis factor (TNF)-α and IL-1β both in the cells that ingest foreign material in tissues (i.e., macrophages) in the lungs and in the white blood cells important in immunity (i.e., monocytes) ([@b51-arh-33-3-203], [@b50-arh-33-3-203], [@b52-arh-33-3-203]; [@b63-arh-33-3-203]; [@b122-arh-33-3-203]; [@b137-arh-33-3-203]; [@b165-arh-33-3-203], [@b166-arh-33-3-203]; [@b174-arh-33-3-203]). Suppression of these immune responses impairs the recruitment of immune cells to sites of infection, and the significance of these immune deficits is well established in the development of bacterial pneumonia and associated disease ([@b12-arh-33-3-203]; [@b74-arh-33-3-203]; [@b121-arh-33-3-203]).

Acute alcohol use also impairs the ability of monocytes and macrophages to bind with molecules that stimulate an immune response (i.e., antigens), thus affecting the efficient production of adaptive immune responses ([@b94-arh-33-3-203]; [@b164-arh-33-3-203]).

### Effects of Chronic Alcohol Exposure

In contrast, chronic alcohol exposure is associated with increased levels of proinflammatory cytokines, including increased TNF-α production by macrophages ([@b72-arh-33-3-203]; [@b99-arh-33-3-203]). Research with macrophages taken from mice chronically exposed to alcohol shows that these cells have increased levels of the proteins that provide a signal necessary for T-cell activation and survival and that they secrete higher levels of proinflammatory cytokines. Research with mice also has shown that chronic alcohol consumption is associated with more severe lung disease from respiratory syncytial virus ([@b64-arh-33-3-203]). Similarly, chronic alcohol exposure increases the severity of influenza virus--induced disease in the lungs of mice, with increased white blood cell recruitment to the lung, resulting in more severe lung tissue damage and progressive loss of CD8^+^ T-cell function ([@b108-arh-33-3-203]).

Chronic alcohol consumption, as well as in vitro alcohol exposure, also has been shown to inhibit cytokine production and the functioning of immune cells known as myeloid dendritic cells that process antigen material and present it on the surface to other cells of the immune system ([@b78-arh-33-3-203]). Recent research ([@b150-arh-33-3-203]) has shown that chronic alcohol exposure decreases the number of myeloid dendritic cells in both the bone marrow and circulating throughout the body. Additionally, the expression of proteins important in immune system signaling is suppressed, potentially attenuating antigen presentation and T-cell activation.

Alcohol also inhibits the immune response by decreasing T-cell proliferative responses in vitro and in vivo ([@b19-arh-33-3-203]; [@b26-arh-33-3-203]; [@b68-arh-33-3-203]), reducing the numbers of CD4^+^ and CD8^+^ T-cells, as well as of immune cells known as natural killer (NK) cells, and altering cell-mediated immunity and cytokine production ([@b34-arh-33-3-203]; [@b94-arh-33-3-203]; [@b102-arh-33-3-203]; [@b149-arh-33-3-203]; [@b154-arh-33-3-203]; [@b160-arh-33-3-203]).

Recent studies in mice on the effects of chronic alcohol exposure on the proliferative responses of both CD4^+^ and CD8^+^ T-cells to specific bacteria antigens showed that chronic alcohol did not affect CD4^+^ T-cell responses but significantly reduced the number of CD8^+^ T-cells responsive to the bacteria and reduced CD8^+^ T-cell proliferation in vivo and in vitro ([@b57-arh-33-3-203]).

Increased levels of antibodies have been observed in chronic alcoholics and are associated with increased incidence of autoimmunity. However, the overall number and function of B-cells, which produce antibodies, do not appear to be affected by alcohol ([@b32-arh-33-3-203]; [@b129-arh-33-3-203]). Collectively, these studies demonstrate that alcohol alters the number and function of immune-cell subsets that play an important role in HIV pathogenesis and thus identify several possible mechanisms through which alcohol consumption may interfere with the natural history of HIV.

Alcohol's Effects on ARV Treatment
==================================

The development and widespread use of highly active ARV therapy (HAART)[^1^](#fn4-arh-33-3-203){ref-type="fn"}, in which several ARV drugs are taken in combination, has substantially reduced morbidity and mortality from AIDS and transformed the lives of many HIV-infected people around the globe (<http://www.unaids.org/en/KnowledgeCentre/HIVData/GlobalReport/2008/>). However, HAART efficacy is influenced by multiple viral and host factors. The influence of alcohol use on HIV treatment is not yet completely understood and is the subject of intense investigation.

As shown in [figure 3](#f3-arh-33-3-203){ref-type="fig"}, alcohol may effect ART efficacy through diverse mechanisms, including (1) decreasing patient adherence to treatment; (2) altering liver function and ARV drug metabolism; (3) accelerating liver disease in hepatitis C and B, frequent comorbidities in HIV-infected patients; and (4) increasing viral replication or inducing immune activation, which may contribute to a poor HAART response.

Alcohol and Treatment Compliance
--------------------------------

When HAART was first introduced, it became clear that strict compliance to treatment regimens was necessary to achieve undetectable viral loads in HIV-infected patients ([@b45-arh-33-3-203]). Because of the high turnover and mutation rate of HIV and the short half-life of the ARV drugs in use, it is estimated that HIV-infected patients must take 95 percent of their medication in order to avoid the rapid emergence of drug-resistant HIV strains ([@b76-arh-33-3-203]).

HIV patient compliance to ART is a function of numerous parameters, including heath insurance, age, socioeconomic status, gender, drug abuse, anger, persistent symptoms, mental problems, and complexity of treatment ([@b111-arh-33-3-203]). Given the historical association of alcohol abuse with failure to comply with medical treatment, it is not surprising that several studies have demonstrated that alcohol consumption is associated with failure to adhere to prescribed ART ([@b33-arh-33-3-203]; [@b91-arh-33-3-203]; [@b143-arh-33-3-203]). Drinkers have an almost ninefold increase in medication noncompliance compared with sober patients, and the risk of noncompliance correlates with regimen complexity ([@b127-arh-33-3-203]; [@b130-arh-33-3-203]). In the backdrop of ART nonadherence by alcohol abusers, it is particularly difficult to directly assess the effect of alcohol on the virologic (and host immune recovery) response to ART ([@b110-arh-33-3-203]). Although some studies have shown lower virologic response to ART in drinkers, other studies failed to demonstrate that alcohol modulates ART efficacy ([@b43-arh-33-3-203]; [@b142-arh-33-3-203]). Studies in nonhuman primate (NHP) models of AIDS can address this question by allowing the prospective investigation of alcohol-fed, SIV-infected animals treated continuously or intermittently with ARVs during the entire course of SIV infection (acute and chronic) until progression to AIDS.

Alcohol and Drug Metabolism
---------------------------

Many ARV drugs undergo significant metabolism in the liver, and there is substantial opportunity for alcohol to disrupt drug bioconversion in HIV patients. Alcohol and other drugs are metabolized by the same enzymes that are involved in the biotransformation of the ARV drugs into toxic intermediates (i.e., by phase 1 enzymes, such as alcohol dehydrogenase, aldehyde dehydrogenase, xantine oxidase, epoxide hydrolase, and cytochrome P450). The toxic compounds are further inactivated by phase 2 enzymes, such as gluthathione *S*-transferase, *N*-acetyl-transferases, sulfotransferases, UDP-glucuronosyltransferases, and methyl-transferase ([@b76-arh-33-3-203]). Thus, alcoholic HIV-infected patients treated with ARV drugs are at risk for drug-- drug interactions that may either decrease or inappropriately increase the effect of HAART. For example, the plasma concentration of the ARV drug abacavir, which is extensively metabolized by alcohol dehydrogenase, increases up to 41 percent ([@b100-arh-33-3-203]). Another potential consequence of drug-- drug interactions is increased toxicity and development of liver damage in patients who already are at risk for developing liver disease because of the direct toxicity of alcohol.

The type of alcohol (i.e., ethanol) found in beverages, especially in combination with another type of alcohol (i.e., isopentanols) (which also are found in many alcoholic beverages), induces activity of the enzyme cytochrome P4503A4 CYP3A4 in the liver both in vivo and in vitro ([@b75-arh-33-3-203]; [@b89-arh-33-3-203]). This phase 1 enzyme is responsible for the metabolism and degradation of the majority of the drugs included in HAART. Two types of ARV drugs----nonnucleoside reverse transcriptase inhibitors (NNRTIs), including delavirdine, nevirapine and efavirenz, and protease inhibitors (PIs), such as ritonavir, nelfinavir, lopinavir, saquinavir, and indinavir----are all susceptible to increased liver metabolism as a result of alcohol-mediated induction of the CYP3A4 enzyme system. Increased metabolism of the HAART components will result in subtherapeutic drug levels in HIV patients actively abusing alcohol, and this could then readily lead to suboptimal viral control. This scenario is likely underestimated because the routine monitoring of ARV levels is not common in HIV treatment settings.

Given the finding that variability in CYP3A4 activity already is greater in HIV patients than in uninfected control subjects (even in patients not receiving drugs that alter CYP3A4 activity) ([@b151-arh-33-3-203]), it is clear that active alcohol abuse in HIV infection is a common and highly relevant factor capable of altering the pharmacokinetics of ARVs.

Chronic alcohol abuse frequently leads to liver dysfunction and loss of liver tissue (i.e., cirrhosis), such that drugs normally metabolized by the liver may induce liver toxicity because of impaired conversion. Two ARV drugs well-known to cause liver toxicity are ritonavir and nevirapine, and practitioners should use caution when prescribing these drugs to alcoholics with liver disease ([@b97-arh-33-3-203]; [@b161-arh-33-3-203]). In the case of PIs, chronic alcohol use induces additive stress in the endoplasmic reticulum (ER), an organelle with known involvement in PI-induced liver toxicity ([@b65-arh-33-3-203]). All ART agents (particularly PIs) should be used with caution, and liver function should be frequently monitored in HIV patients with alcohol use disorders.

Effect of Alcohol on Coinfections
---------------------------------

An additional risk for alcohol use to complicate HAART is coinfection with viral hepatitis. Approximately 30 percent of HIV patients are coinfected with the hepatitis C virus (HCV), and approximately 10 percent are coinfected with the hepatitis B virus ([@b155-arh-33-3-203], [@b156-arh-33-3-203]). Heavy alcohol use is an additional risk factor for scarring of the liver (i.e., fibrosis) and cirrhosis in these patients ([@b9-arh-33-3-203]; [@b41-arh-33-3-203]). The incidence of ART liver toxicity is increased in coinfected individuals ([@b36-arh-33-3-203]; [@b161-arh-33-3-203], [@b162-arh-33-3-203]), and alcohol is an independent risk factor for liver injury during ART initiation, especially in HIV patients infected with HCV ([@b124-arh-33-3-203]). Also, compared with HIV infection alone, the efficacy of ART in HIV/HCV coinfected patients is impaired in its ability to restore blood CD4^+^ T-cell counts ([@b54-arh-33-3-203]).

Other Effects of Interactions Between Alcohol and ARV Drugs
-----------------------------------------------------------

A well-known complication of the ARV drug didanosine in alcoholic HIV-infected patients is inflammation of the pancreas ([@b177-arh-33-3-203]; [@b180-arh-33-3-203]). This medication therefore should be eliminated from the ART regimens in patients who are actively drinking.

Damage to the parts of the nervous system that carry information throughout the body (i.e., peripheral neuropathy) is another complication of chronic alcohol abuse and, given their neuropathic side effects, limits the use of the NRTIs zalcitabine and stavudine in alcoholics ([@b117-arh-33-3-203]). Alcohol also increases heart disease risk among patients on ART ([@b109-arh-33-3-203]).

Effects of Alcohol on Viral Replication and Host Immune System
--------------------------------------------------------------

Alcohol may increase viral replication, per se, and thus contribute to therapy failure. Also, by activating CD4^+^ T-cells, alcohol may fuel viral replication by increasing the number of target cells and impairing the recovery of CD4^+^ T-cells circulating in the body and cells in mucosal sites (e.g., inside the mouth or nose) after ART, even when controlling for ART compliance ([@b144-arh-33-3-203]).

Given the central role of HAART in HIV disease management, a more robust understanding of the direct role that alcohol plays in disturbing host and pathogen responses to treatment is clearly needed to better address the needs of these patients. NHP models of AIDS may help define all the facets of alcohol's effects on ART.

Animal Models for Studying Alcohol Use and HIV Infection
========================================================

Although mouse and rat models have been used intensively to investigate alcohol's effects on innate and adaptive immune responses ([@b11-arh-33-3-203], [@b12-arh-33-3-203]; [@b20-arh-33-3-203]; [@b42-arh-33-3-203]; [@b57-arh-33-3-203]; [@b59-arh-33-3-203]; [@b66-arh-33-3-203]; [@b80-arh-33-3-203]; [@b92-arh-33-3-203]; [@b108-arh-33-3-203]; [@b123-arh-33-3-203]; [@b138-arh-33-3-203]; [@b181-arh-33-3-203]; [@b182-arh-33-3-203]), such models cannot be used to investigate the role of alcohol in the natural history of HIV. Mice immunodeficiency models do not faithfully reproduce HIV pathogenesis. NHPs, which are genetically close to humans and can be infected with retroviruses related to HIV, may therefore be more valuable models for deciphering the role of alcohol in transmission, pathogenesis, and treatment of retroviruses. This section will present the NHP models currently available for the study of alcohol's effects on HIV pathogenesis, their characteristics, and their potential use in studies modeling the effect of alcohol in HIV infection.

NHP Models for Pathogenic SIV Infection
---------------------------------------

SIV was discovered a few years after the discovery of HIV ([@b35-arh-33-3-203]; [@b85-arh-33-3-203]). SIV infection in rhesus macaques closely mimics HIV's pathogenesis, virology, immunology, and pathology in humans, and the progression to AIDS also is similar.

Research Applications
---------------------

Over the years, this model has been used for vaccine research ([@b38-arh-33-3-203]) and to demonstrate some of the key features of HIV infections ([@b153-arh-33-3-203]; [@b172-arh-33-3-203]). Recently, researchers also have studied virus transmission and dissemination from the mucosal sites of entry in macaques ([@b70-arh-33-3-203]; [@b93-arh-33-3-203]). Therapeutic studies in macaques were used to develop several classes of ARV drugs ([@b170-arh-33-3-203]). Macaques infected with a subtype of SIV, SIVsmm, also served as an animal model for transmission of virus during breastfeeding ([@b2-arh-33-3-203]). Finally, macaque studies permit invasive approaches of selective depletion of specific components of the immune system to investigate the correlates of disease progression ([@b48-arh-33-3-203]; [@b146-arh-33-3-203], [@b147-arh-33-3-203]).

SIV Pathogenesis
================

Similar to HIV infection in humans, SIV in rhesus macaques progresses to AIDS in a variable time frame ([@b61-arh-33-3-203]). The hallmarks of pathogenic infection are (1) massive, continuous viral replication ([@b62-arh-33-3-203]; [@b131-arh-33-3-203]; [@b176-arh-33-3-203]), with the amount of HIV in the blood after stabilizing (i.e., viral load set point) predicting the time of progression to AIDS ([@b105-arh-33-3-203]; [@b107-arh-33-3-203], [@b106-arh-33-3-203]); (2) continuous depletion of CD4^+^ T-cells in the bloodstream ([@b17-arh-33-3-203]; [@b55-arh-33-3-203]) that is more pronounced at mucosal sites ([@b18-arh-33-3-203]; [@b86-arh-33-3-203]; [@b98-arh-33-3-203]; [@b103-arh-33-3-203]; [@b132-arh-33-3-203]; [@b172-arh-33-3-203]); and (3) high levels of T-cell immune activation ([@b49-arh-33-3-203]; [@b157-arh-33-3-203]), the magnitude of which has been reported to be predictive of disease progression ([@b49-arh-33-3-203]; [@b157-arh-33-3-203]). The interaction among these factors cripples the immune system and eventually results in severe immunodeficiency and death ([@b17-arh-33-3-203]; [@b17-arh-33-3-203]; [@b55-arh-33-3-203]; [@b128-arh-33-3-203]).

Immune Responses
----------------

HIV and SIV infections induce immune responses characterized by robust antibody-mediated (i.e., humoral) and cellular immune responses ([@b15-arh-33-3-203]; [@b37-arh-33-3-203]; [@b141-arh-33-3-203]). However, the role of these responses in controlling viral replication still is unclear. Moreover, continuous immune escape (i.e., virus evasion from specific immune responses) is the hallmark of HIV/SIV infection in pathogenic models ([@b21-arh-33-3-203]). Interestingly, during acute SIV/HIV infection, CD4^+^ T-cell levels in the blood show only modest decline. Numerous studies in the SIV macaque model ([@b86-arh-33-3-203]; [@b98-arh-33-3-203]; [@b152-arh-33-3-203]; [@b172-arh-33-3-203]) demonstrated that a massive CD4^+^ T-cell depletion first occurs at the mucosal level, where the majority of lymphocytes (i.e., white blood cells, including T-cells) reside. More recent studies ([@b86-arh-33-3-203]; [@b98-arh-33-3-203]) investigated the mechanism of T-cell destruction during acute infection, including destruction of a subset of CD4^+^ T-cells that recognize and respond to a particular antigen (i.e., CD4^+^ memory T-cells). Together, these reports document a massive destruction of CD4^+^ memory T-cells at multiple tissue sites during acute infection.

Following HIV/SIV infection, heightened immune activation commonly is manifested and associated with increased rates of T-cell destruction, and, as a consequence, increased rates of cell proliferation, increased expression of factors that support programmed cell death (i.e. apoptosis), and disruption of lymphoid and bone marrow architecture resulting in reduced T-cell regenerative capacity ([@b49-arh-33-3-203]; [@b56-arh-33-3-203]; [@b118-arh-33-3-203]; [@b157-arh-33-3-203]). It recently was suggested that because of compromised mucosal immunity, a greater number of symbiotic and opportunistic bacteria can enter the lymphatic system and blood of the SIV-infected macaques and HIV-infected humans. This theory (known as the microbial translocation hypothesis) is based on recent studies that identified elevated levels of the endotoxin lipopolysaccharide (LPS) in the plasma of HIV-infected patients and SIV-infected macaques ([@b17-arh-33-3-203]). Microbial translocation is the most compelling hypothesis put forth to explain the high levels of immune activation in the pathogenic SIV/HIV infections. This hypothesis centers on the role of a type of receptor that recognizes specific molecules derived from microbes (i.e., toll-like receptors) in the induction of the increased systemic immune activation observed in these progressive infections ([@b17-arh-33-3-203]). Chronic, heightened levels of immune activation during SIV/HIV infection result in the dysfunction of numerous immune cell types ([@b1-arh-33-3-203]; [@b16-arh-33-3-203]; [@b22-arh-33-3-203]; [@b28-arh-33-3-203]; [@b67-arh-33-3-203]; [@b84-arh-33-3-203]; [@b96-arh-33-3-203]) that contribute to AIDS progression.

Advantages
----------

Because of its close similarity to HIV infection, the model of SIV infection of rhesus macaques offers several advantages in identifying the role of alcohol consumption in the natural history of AIDS. These include the ability to (1) control the time and route of infection; (2) monitor and control nutritional and behavioral variables; (3) manipulate and control the timing and quantity of alcohol consumption; (4) conduct longitudinal studies because the duration of infection from its inception to terminal disease with virulent strains of SIV typically is less than 2 years, with greater than 50 percent of the animals euthanized with AIDS within 1 year of inoculation if they are not treated with ARV drugs; and (5) perform studies with and without antiviral therapy. These advantages and the ability to administer alcohol to rhesus macaques makes this model ideal for studying the biomedical impact of alcohol on HIV disease transmission, progression to AIDS, and treatment.

Research Findings From an SIV Alcohol Model
===========================================

To study the effect of alcohol on SIV infection in rhesus macaques, the authors developed a model in which intoxicating amounts of alcohol are delivered via a permanently implanted stomach tube ([@b7-arh-33-3-203]; [@b179-arh-33-3-203]). This alcohol-- rhesus macaque model has been used to study the impact of alcohol on (1) SIV disease progression ([@b8-arh-33-3-203]); (2) SIV expression in mucosally inoculated macaques ([@b136-arh-33-3-203]); (3) intestinal lymphocyte subsets and turnover before and during SIV infection ([@b135-arh-33-3-203]); (4) nutritional, metabolic, and immune alterations during asymptomatic SIV infection ([@b114-arh-33-3-203]); (5) SIV-associated weight loss ([@b113-arh-33-3-203]); (6) myeloid dendritic cell function ([@b150-arh-33-3-203]); (7) adaptive host defense response to SIV infection; (8) lung SIV expression during pneumococcal pneumonia; (9) neuropsychological deficits during SIV infection ([@b179-arh-33-3-203]); and (10) the development of an ART model. Together, these studies have shown that alcohol has significant impact on SIV infection.

Alcohol and Disease Progression
-------------------------------

In a major longitudinal study, researchers found that alcohol administration to SIV-infected rhesus macaques resulted in accelerated progression to end-stage disease (see [figure 4](#f4-arh-33-3-203){ref-type="fig"}). Thus, median time of survival decreased from 900 days in sucrose-treated animals to 374 days in alcohol-administered animals ([@b8-arh-33-3-203]).

Alcohol and Viral Replication
-----------------------------

In two separate animal studies, researchers reported increased plasma viral loads in alcohol-treated SIV-infected rhesus macaques compared with sucrose-treated animals ([@b8-arh-33-3-203]; [@b136-arh-33-3-203]). Alcohol administration increases virus levels in plasma by 10- to 100-fold at viral load set point, and SIV was associated with more rapid disease progression in rhesus macaques inoculated either intravenously (see [figure 5](#f5-arh-33-3-203){ref-type="fig"}) or mucosally. [@b135-arh-33-3-203] also found consistent increases in viral expression in lymphoid tissue and the intestine in alcohol-treated animals. In a recent study ([@b136-arh-33-3-203]), SIV RNA levels were higher in the fluid obtained from the lungs of alcohol-treated animals compared with controls. An additional study by [@b77-arh-33-3-203] also demonstrated increased viral replication in the plasma of chronically simian-human immunodeficiency virus (SHIV)/SIV-infected rhesus macaques after a 7-week period of alcohol consumption. The same study reported higher viral loads in the brains of the alcohol-dependent animals compared with control animals. In this study, the increased viral replication was associated with significantly higher CD4^+^ T-cell loss in the alcohol-treated animals ([@b77-arh-33-3-203]). Thus, the increased viral turnover in plasma and tissues may explain the accelerated progression to AIDS in the rhesus macaque model.

Alcohol and T-Cell Subsets
--------------------------

A recent study on subsets of T-cells ([@b135-arh-33-3-203]) has shown that the percentage of CD8^+^ T-cells in the small intestine of alcohol-consuming macaques was significantly lower than in sucrose-consuming macaques both before infection as well as in the early postinfection period. Also, the percentage of CD4^+^CD3^+^ lymphocytes in the intestine was significantly higher in alcohol-consuming macaques before infection. To understand the possible reasons behind the increased viral replication, researchers further investigated the effects of chronic alcohol consumption on the percentages of different kinds of lymphocytes in the blood, lymph nodes, and intestine. Although minimal differences were detected in blood and lymph nodes, there were significantly higher percentages of memory T-cells in the intestines from alcohol-receiving animals before infection compared with controls. In addition, higher percentages of antigennaïve T-cells as well as CXCR4^+^CD4^+^ T-cells were detected in intestines of alcohol-treated macaques. Moreover, alcohol consumption resulted in significantly lower percentages of a subtype of memory CD8^+^ T-cell that stimulates other cells (i.e., effector memory cells) as well as activated Ki67^+^CD8^+^ cells in the intestine. Central memory CD4^+^ lymphocytes were significantly depleted in intestines and mesenteric lymph nodes from all alcohol animals at 8 weeks postinfection ([@b135-arh-33-3-203]).

These findings suggest that a higher percentage of SIV target cells (memory CD4^+^ T-cells) in the gut, coupled with lower percentages of effector CD8^+^ T-cells (which could be important in controlling virus replication), may be responsible for the higher SIV loads observed in alcohol-consuming macaques ([@b135-arh-33-3-203]).

Using a SIV--macaque model of chronic alcohol self-administration, [@b95-arh-33-3-203] also have observed several immunologic changes during the acute phase of infection. These included reduced percentages of circulating memory CD4^+^ T-cells in alcohol-treated animals 7 days after infection, as well as increased levels of CCR5-expressing monocytes 12 days after infection in alcohol-treated animals compared with controls. These data also suggest that alcohol has detrimental effects on the host immune system by increasing depletion of CD4^+^ T-cells and inducing immune activation of other cell subsets that may serve as target cells ([@b95-arh-33-3-203]).

Thus, changes in the circulating and mucosal immune compartments in response to alcohol likely are the major reasons behind higher replication of SIV and rapid disease progression observed in these animals.

[@b135-arh-33-3-203] have reported a positive correlation between the number of blood CD4^+^ T-cells and viral load in alcohol-treated animals but not in sucrose-treated control animals. More work is needed, but these observations support the hypothesis that alcohol increases virus production by activating CD4^+^ T-cells.

SIV, Alcohol, and Body Weight
-----------------------------

[@b8-arh-33-3-203] reported that body weight loss was more frequently observed in alcohol-fed macaques with end-stage disease than it was in control animals. In other research, [@b114-arh-33-3-203] observed greater decreases in caloric intake and nitrogen balance in alcohol-receiving monkeys prior to developing AIDS. Although this was not associated with decreased muscle protein synthesis at a relatively early stage of disease, genetic material for the proinflammatory cytokine TNF--α was increased in muscle from alcohol-fed macaques compared with sucrose-treated animals, indicative of a proinflammatory state that might be conducive to later muscle wasting. Such wasting was observed when alcohol-treated animals were followed to end-stage disease ([@b113-arh-33-3-203]). In this study, alcohol-treated animals with AIDS had significantly lower body weights and limb muscle than did control animals. Research suggests that muscle wasting results from a proinflammatory state, leading to increased muscle weakening via enzymatic breakdown of proteins. These changes in alcohol-fed animals may be in part responsible for their accelerated disease progression during SIV infection.

Perspectives
============

Altogether, these results show that alcohol severely affects the natural history of AIDS. Data suggest that the increased SIV levels observed in alcohol-consuming animals may represent an increase in virus production as opposed to a decrease in host defense. Results also suggest that changes in nutritional balance and metabolism as a possible consequence of a proinflammatory state, together with increased virus production in animals consuming alcohol, accelerate SIV and possibly HIV disease progression. More studies using the animal model are necessary in order to determine whether mucosal adaptive immune responses are altered by alcohol.

Mucosal cytotoxic CD8^+^ T-cell responses are important to viral control during SIV infection ([@b71-arh-33-3-203]; [@b171-arh-33-3-203]). The administration of ART to animals early in the course of SIV infection is associated with the development of SIV-specific CD8^+^ T-cells that secrete IL-2, a response that may support gut CD4^+^ T-cell recovery ([@b173-arh-33-3-203]). In addition, ART is associated with decreased markers of CD8^+^ T-cell proliferation/activation, which may decrease the overall inflammatory milieu of the mucosa. Because ethanol is known to cause mucosal injury/inflammation and decreases mucosal CD8^+^ T-cell populations ([@b135-arh-33-3-203]), it is possible that chronic alcohol feeding could detrimentally affect the quality and quantity of cytotoxic mucosal CD8^+^ T-cells during ART.

Alcohol may increase viral replication either by directly increasing the activity of nuclear factor κB, which regulates genes involved in the immune response, or by increasing cell immune activation and thus the pool of target cells (see [figure 6](#f6-arh-33-3-203){ref-type="fig"}).

Alcohol and Intestinal Inflammation
-----------------------------------

Chronic ethanol intake is associated with increased intestinal inflammation, decreased expression of proteins that form fluid-impermeable barriers (i.e., tight junction proteins), and impaired barrier integrity ([@b167-arh-33-3-203]). Research with humans indicates that alcoholics have "leaky" small bowel, and this defect may drive both local and systemic inflammation ([@b10-arh-33-3-203]). Epigenetic consequences of alcohol abuse may mediate increases in gut permeability. Colonic biopsies from alcoholics (with liver disease) demonstrate increased expression of a microRNA species (i.e., miR-212) that targets transcripts for a specific tight junction protein ([@b167-arh-33-3-203]). The same study showed that miR-212 expression directly correlates with intestinal epithelial permeability. Alcohol also may contribute to loss of gut integrity by reducing the numbers of intestinal Th17 cells, a T-cell subset reported to play an important role in maintenance of mucosal epithelial integrity ([@b44-arh-33-3-203]) (see [figure 6](#f6-arh-33-3-203){ref-type="fig"}).

Increased gut permeability also has been described during SIV/HIV infection progression and may play a role in increasing systemic inflammation and virus spread. Thus, the additional alcohol--induced gut injury may directly accelerate progression to AIDS through additional increases in immune activation (see [figure 6](#f6-arh-33-3-203){ref-type="fig"}). Alcohol also may induce immune activation through modifications in the numbers of T--regulatory cells, which inhibit the activation and proliferation of T-cells (see [figure 6](#f6-arh-33-3-203){ref-type="fig"}).

Alcohol and Immune Activation
-----------------------------

By increasing levels of immune activation, alcohol may contribute to increased levels of virus replication and consequently accelerated and more pronounced CD4^+^ T-cell depletion at mucosal sites. Hence, the data obtained using the alcohol--rhesus macaque model clearly demonstrates the adverse effects of ethanol consumption on SIV infection.

NHP studies have shown that ART, when given soon after SIV infection, can protect intestinal memory CD4^+^ T-cells from rapid depletion ([@b87-arh-33-3-203]). Moreover, additional studies demonstrated the ability of ART to permit reconstitution of gut CD4^+^ T-cell populations when given 7 days after SIV infection ([@b173-arh-33-3-203]). However, recent studies of HIV patients who started ART relatively soon after HIV infection suggested that early ART treatment may have a limited impact on recovery of gut memory CD4^+^ T-cells ([@b104-arh-33-3-203]). The disparity between ART studies in HIV-infected patients and SIV-infected NHPs raises the question whether additional factors in human infection, such as alcohol abuse and/or medication compliance, lessen the efficacy of ART. Alcohol abusers are frequently noncompliant with therapy, and this behavior may be at least partially responsible for observations of decreased benefits from ART treatment in this group ([@b144-arh-33-3-203]; see also the article by Samet in this issue). It also is plausible that increases in viral replication associated with chronic ethanol abuse will increase the number of CD4^+^ T-cells directly destroyed by the virus. Alcohol also may increase CD4^+^ T-cell destruction through increasing immune activation and apoptosis (a mechanism that was reported to be responsible for the death of the majority of CD4^+^ T-cells in HIV-infected humans and SIV-infected macaques). Thus, alcohol may directly interfere with ART capacity to control viral replication and allow CD4^+^ T-cell recovery (see [figure 6](#f6-arh-33-3-203){ref-type="fig"}).

The alcohol--rhesus macaque model is thus ideal to investigate the role of alcohol in modulation of viral replication, mucosal adaptive immune responses, levels of immune activation, levels of apoptosis, numbers of mucosal CD4^+^ T-cells, and ART efficacy because it allows (1) multiple invasive procedures that are necessary to recover gut tissue, (2) sampling at defined time points during the SIV infection, and (3) precisely monitored treatment with ART.

In summary, there is substantial scientific evidence on the adverse consequences of alcohol abuse on HIV infection. The behavioral, virologic, pharmacologic, and immunologic effects of ethanol combine to result in suboptimal treatment responses and the more rapid development of AIDS. Future studies are necessary to decipher the precise mechanisms through which alcohol alters the virus biology and the host immune responses.
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The acronym HAART now is used interchangeably with the term antiretroviral therapy (ART). Initially, the term HAART was coined to describe the use of a combination of drugs versus a single drug during treatment. Today, all treatments use a combination of drugs; therefore, HAART and ART are equivalent.
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![Alcohol consumption may facilitate human immunodeficiency virus (HIV) transmission through risky sexual behavior, increased HIV shedding, and increased inflammation at mucosal sites.\
NOTES: STD, sexually transmitted disease.](arh-33-3-203f2){#f2-arh-33-3-203}
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![Alcohol administration impacted survival in simian immunodeficiency virus (SIV)-infected rhesus macaques.\
NOTE: Reproduced with permission from [@b8-arh-33-3-203].](arh-33-3-203f4){#f4-arh-33-3-203}

![Alcohol administration results in an increase of simian immunodeficiency virus (SIV) replication in rhesus macaques.](arh-33-3-203f5){#f5-arh-33-3-203}

![Potential mechanisms of the immune dysfunction induced by alcohol consumption.\
NOTE: LPS=lipopolysaccharide; NFkB=nuclear factor KB; Tregs=Regulatory T-cells](arh-33-3-203f6){#f6-arh-33-3-203}
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